Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
20 juil. 2023 16h05 HE
|
Codexis, Inc.
Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis™ Platform for RNAi Therapeutics Production Codexis Expects its Pharmaceutical Manufacturing Business...
Codexis Announces New Employment Inducement Grants
09 juin 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to four new employees as...
Codexis to Participate in Jefferies Healthcare Conference
24 mai 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Healthcare...
Codexis Unveils ECO Synthesis™ Platform for Large-Scale RNAi Therapeutics Production at TIDES USA
10 mai 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the unveiling of its Enzyme-Catalyzed Oligonucleotide (ECO)...
Codexis Announces New Employment Inducement Grants
08 mai 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to five new employees as...
Codexis Reports First Quarter 2023 Financial Results
04 mai 2023 16h05 HE
|
Codexis, Inc.
CDX-7108 Clinical Development Program Remains on Track Estimated Cash Runway Through End of 2024 Funds Important Upcoming Milestones Company Reiterates 2023 Total Revenue Guidance with...
Codexis to Report First Quarter 2023 Financial Results on May 4
20 avr. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first...
Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA
19 avr. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a pre-conference workshop highlighting the...
Codexis Announces New Employment Inducement Grants
06 avr. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as...
Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors
04 avr. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that Patrick Yang, PhD, will not seek re-election to the...